Acute Myeloid Leukemia (AML): Causes, Symptoms, Diagnosis, and Treatment

Introduction

Acute myeloid leukemia (AML) is an aggressive form of cancer that affects the bone marrow and blood. It develops when immature white blood cells (myeloblasts) grow uncontrollably, interfering with the production of healthy blood cells. AML can progress rapidly, requiring immediate diagnosis and treatment to improve prognosis.

Although AML primarily affects older adults, it can also occur in younger people, including children. With advancements in medical research, treatment options and survival rates have significantly improved.

What is Acute Myeloid Leukemia?

Acute myeloid leukemia is a type of blood cancer that originates in the myeloid cell line of the bone marrow. It leads to the overproduction of abnormal white blood cells, crowding out normal cells and impairing the blood’s ability to carry oxygen, fight infections, and control bleeding.

Symptoms of Acute Myeloid Leukemia

Symptoms of AML may develop suddenly or worsen quickly. Common signs include:

Fatigue or weakness
Fever and recurrent infections
Easy bruising or bleeding, including nosebleeds or heavy menstruation
Pale skin (due to anemia)
Bone or joint pain
Swollen lymph nodes
Shortness of breath
Loss of appetite and weight loss
Frequent nosebleeds or bleeding gums
Skin rashes or pinpoint red spots (petechiae)

Causes and Risk Factors of AML

AML develops due to genetic mutations in the bone marrow that result in uncontrolled growth of immature blood cells. While the exact cause is unknown, certain factors can increase the risk.

Risk Factors:

Age:
- AML is more common in people aged 65 and older.
Previous Cancer Treatment:
- Chemotherapy or radiation therapy for other cancers may increase the risk.
Genetic Disorders:
- Down syndrome and other inherited syndromes.
Exposure to Chemicals:
- Benzene and other toxic chemicals.
Smoking:
- Smoking introduces harmful chemicals into the bloodstream.
Radiation Exposure:
- High doses of radiation, such as during nuclear accidents.
Blood Disorders:
- Conditions like myelodysplastic syndromes or aplastic anemia may evolve into AML.

Diagnosis of Acute Myeloid Leukemia

AML is diagnosed using a combination of blood tests, bone marrow analysis, and imaging.

Common Diagnostic Tests:

Blood Tests:
- Complete blood count (CBC) to detect abnormal white blood cells, low red blood cells, and platelets.
- Peripheral blood smear to identify myeloblasts.
Bone Marrow Biopsy:
- Confirms the presence of leukemic cells in the bone marrow.
Cytogenetic Testing:
- Detects chromosomal abnormalities to classify AML subtypes and guide treatment.
Flow Cytometry:
- Determines the type of leukemia by analyzing cell markers.
Imaging Tests:
- CT scans or X-rays may be used to detect organ involvement.

Treatment for Acute Myeloid Leukemia

The treatment of AML typically involves intensive therapy to eradicate leukemic cells and restore normal blood production.

1. Chemotherapy:

The primary treatment for AML, delivered in two phases:
- Induction Therapy: Eliminates as many leukemia cells as possible.
- Consolidation Therapy: Prevents relapse by targeting remaining leukemia cells.
Common drugs include cytarabine and daunorubicin.

2. Targeted Therapy:

Medications like gilteritinib or midostaurin are used for specific genetic mutations such as FLT3.

3. Stem Cell Transplant (Bone Marrow Transplant):

Replaces diseased bone marrow with healthy stem cells from a donor after high-dose chemotherapy or radiation.

4. Clinical Trials:

Participation in trials for new drugs or therapies may be an option for some patients.

Prognosis and Survival Rates

The prognosis for AML varies based on factors like age, overall health, and the presence of specific genetic mutations.

Children:
- The 5-year survival rate for pediatric AML is approximately 60–70%.
Adults:
- Survival rates decrease with age but are improving with targeted therapies.

Complications of Acute Myeloid Leukemia

Without timely treatment, AML can lead to severe complications, including:

Life-threatening infections
Severe anemia
Uncontrolled bleeding
Organ failure due to leukemic infiltration
Relapse after treatment

Prevention of Acute Myeloid Leukemia

While AML cannot always be prevented, certain measures may reduce risk:

Avoid smoking and exposure to toxic chemicals.
Minimize radiation exposure when possible.
Manage underlying blood disorders promptly.
Regular health screenings for individuals with genetic predispositions.

Frequently Asked Questions (FAQ)

Q: How does AML differ from ALL?
A: While both are acute leukemias, AML affects the myeloid cell line, whereas acute lymphoblastic leukemia (ALL) affects the lymphoid cell line.

Q: Can AML be cured?
A: Many patients achieve remission, and some are cured, especially with stem cell transplants or targeted therapies.

Q: How long does AML treatment last?
A: Treatment can last several months, including induction and consolidation therapy, with additional time for recovery or further treatments if needed.

Q: Is AML hereditary?
A: Most cases are not inherited, but certain genetic disorders may increase risk.

Takeaway

Acute myeloid leukemia is an aggressive blood cancer requiring prompt diagnosis and treatment. Advances in chemotherapy, targeted therapy, and bone marrow transplantation have improved survival rates. If you or a loved one shows symptoms of AML, consult a healthcare provider immediately.

Best Guider